Oxford Biomedica (LON:OXB) Stock Price Passes Below 200-Day Moving Average – Here’s Why

Oxford Biomedica plc (LON:OXB) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 389.35 ($5.01) and traded as low as GBX 285 ($3.67). Oxford Biomedica shares last traded at GBX 286 ($3.68), with a volume of 189,113 shares.

Oxford Biomedica Stock Down 2.7 %

The company has a market cap of £304.02 million, a price-to-earnings ratio of -2.12 and a beta of 1.09. The company has a debt-to-equity ratio of 166.48, a quick ratio of 1.67 and a current ratio of 2.35. The business’s 50 day simple moving average is GBX 384.97 and its 200-day simple moving average is GBX 389.35.

About Oxford Biomedica

Oxford Biomedica (LSE: OXB) is a quality and innovation-led cell and gene therapy CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world.

One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.